These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33029088)

  • 1. An α
    Weng X; Liu H; Zhang X; Sun Q; Li C; Gu M; Xu Y; Li S; Li W; Du J
    Int J Med Sci; 2020; 17(16):2454-2467. PubMed ID: 33029088
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexmedetomidine attenuates H2O2-induced neonatal rat cardiomyocytes apoptosis through mitochondria- and ER-medicated oxidative stress pathways.
    Liu XR; Li T; Cao L; Yu YY; Chen LL; Fan XH; Yang BB; Tan XQ
    Mol Med Rep; 2018 May; 17(5):7258-7264. PubMed ID: 29568958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
    Riquelme JA; Westermeier F; Hall AR; Vicencio JM; Pedrozo Z; Ibacache M; Fuenzalida B; Sobrevia L; Davidson SM; Yellon DM; Sánchez G; Lavandero S
    Pharmacol Res; 2016 Jan; 103():318-27. PubMed ID: 26607864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of thioredoxin 2 alters mitochondrial respiratory function and induces cardiomyocyte hypertrophy.
    Hu C; Zhang H; Qiao Z; Wang Y; Zhang P; Yang D
    Exp Cell Res; 2018 Nov; 372(1):61-72. PubMed ID: 30236513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
    Chen Y; Huang Y; Xiong B; Luo H; Song X
    Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine alleviates cardiomyocyte apoptosis and cardiac dysfunction may be associated with inhibition of RhoA/ROCK pathway in mice with myocardial infarction.
    Sun T; Gong Q; Wu Y; Shen Z; Zhang Y; Ge S; Duan JS
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1569-1577. PubMed ID: 33782744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
    Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
    Bao N; Tang B; Wang J
    J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.
    Gao J; Sun Z; Xiao Z; Du Q; Niu X; Wang G; Chang YW; Sun Y; Sun W; Lin A; Bresnahan JC; Maze M; Beattie MS; Pan JZ
    Br J Anaesth; 2019 Dec; 123(6):827-838. PubMed ID: 31623841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced mitochondrial response sensitivity is involved in the anti‑apoptotic effect of dexmedetomidine pretreatment in cardiomyocytes.
    Weng X; Zhang X; Lu X; Wu J; Li S
    Int J Mol Med; 2018 Apr; 41(4):2328-2338. PubMed ID: 29328437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine alleviates H
    Yin W; Wang C; Peng Y; Yuan W; Zhang Z; Liu H; Xia Z; Ren C; Qian J
    Mol Biol Rep; 2020 May; 47(5):3629-3639. PubMed ID: 32342432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine protects mice against myocardium ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS pathway.
    Sun Y; Jiang C; Jiang J; Qiu L
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):946-953. PubMed ID: 28556946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
    Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
    Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
    Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine maintains blood-brain barrier integrity by inhibiting Drp1-related endothelial mitochondrial dysfunction in ischemic stroke.
    Zhou W; Zhang Y; Jiao Y; Yin W; Dong H; Xu S; Tang D; Jiang J; Shao J; Wang Z; Yu W
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1177-1188. PubMed ID: 34244711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
    Jesus ICG; Scalzo S; Alves F; Marques K; Rocha-Resende C; Bader M; Santos RAS; Guatimosim S
    Am J Physiol Cell Physiol; 2018 Jun; 314(6):C702-C711. PubMed ID: 29443552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy.
    Gao M; Hu F; Hu M; Hu Y; Shi H; Zhao GJ; Jian C; Ji YX; Zhang XJ; She ZG; Li H; Zhu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 32964914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
    Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
    J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
    Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
    Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.